415 related articles for article (PubMed ID: 14508824)
1. c-Met expression in tall cell variant papillary carcinoma of the thyroid.
Nardone HC; Ziober AF; LiVolsi VA; Mandel SJ; Baloch ZW; Weber RS; Mick R; Ziober BL
Cancer; 2003 Oct; 98(7):1386-93. PubMed ID: 14508824
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy.
Siraj AK; Bavi P; Abubaker J; Jehan Z; Sultana M; Al-Dayel F; Al-Nuaim A; Alzahrani A; Ahmed M; Al-Sanea O; Uddin S; Al-Kuraya KS
J Pathol; 2007 Oct; 213(2):190-9. PubMed ID: 17703498
[TBL] [Abstract][Full Text] [Related]
3. Expression and significance of c-met protein in papillary thyroid carcinoma.
Inaba M; Sato H; Abe Y; Umemura S; Ito K; Sakai H
Tokai J Exp Clin Med; 2002 Aug; 27(2):43-9. PubMed ID: 12472169
[TBL] [Abstract][Full Text] [Related]
4. The tall cell variant of papillary carcinoma of the thyroid gland. Comparison with the common form of papillary carcinoma by DNA and morphometric analysis.
Flint A; Davenport RD; Lloyd RV
Arch Pathol Lab Med; 1991 Feb; 115(2):169-71. PubMed ID: 1992985
[TBL] [Abstract][Full Text] [Related]
5. The expression and role of serum response factor in papillary carcinoma of the thyroid.
Kim HJ; Kim KR; Park HS; Jang KY; Chung MJ; Shong M; Moon WS
Int J Oncol; 2009 Jul; 35(1):49-55. PubMed ID: 19513551
[TBL] [Abstract][Full Text] [Related]
6. Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology.
McCaffrey JC
Laryngoscope; 2006 Jan; 116(1):1-11. PubMed ID: 16481800
[TBL] [Abstract][Full Text] [Related]
7. Difference in patterns of Met expression in papillary thyroid carcinomas and nonneoplastic thyroid tissue.
Fluge Ø ; Haugen DR; Lillehaug JR; Varhaug JE
World J Surg; 2001 May; 25(5):623-31. PubMed ID: 11369990
[TBL] [Abstract][Full Text] [Related]
8. Distinguishing tall cell variant of papillary thyroid carcinoma from usual variant of papillary thyroid carcinoma in cytologic specimens.
Solomon A; Gupta PK; LiVolsi VA; Baloch ZW
Diagn Cytopathol; 2002 Sep; 27(3):143-8. PubMed ID: 12203860
[TBL] [Abstract][Full Text] [Related]
9. Biological significance of c-met over expression in papillary renal cell carcinoma.
Sweeney P; El-Naggar AK; Lin SH; Pisters LL
J Urol; 2002 Jul; 168(1):51-5. PubMed ID: 12050491
[TBL] [Abstract][Full Text] [Related]
10. COX-2 is induced by HGF stimulation in Met-positive thyroid papillary carcinoma cells and is involved in tumour invasiveness.
Scarpino S; Duranti E; Stoppacciaro A; Pilozzi E; Natoli G; Sciacchitano S; Luciani E; Ruco L
J Pathol; 2009 Aug; 218(4):487-94. PubMed ID: 19391129
[TBL] [Abstract][Full Text] [Related]
11. Mixed columnar cell and tall cell variant of papillary carcinoma of thyroid: a case report and review of the literature.
Putti TC; Bhuiya TA
Pathology; 2000 Nov; 32(4):286-9. PubMed ID: 11186427
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas.
Furlan JC; Bedard YC; Rosen IB
J Am Coll Surg; 2004 Mar; 198(3):341-8. PubMed ID: 14992733
[TBL] [Abstract][Full Text] [Related]
13. In situ detection of hTERT mRNA relates to Ki-67 labeling index in papillary thyroid carcinoma.
Chou SJ; Chen CM; Harn HJ; Chen CJ; Liu YC
J Surg Res; 2001 Jul; 99(1):75-83. PubMed ID: 11421607
[TBL] [Abstract][Full Text] [Related]
14. Tall cell variant of papillary thyroid carcinoma: Its characteristic features demonstrated by fine-needle aspiration cytology and immunohistochemical study.
Urano M; Kiriyama Y; Takakuwa Y; Kuroda M
Diagn Cytopathol; 2009 Oct; 37(10):732-7. PubMed ID: 19373912
[TBL] [Abstract][Full Text] [Related]
15. Expression of Met protein and urokinase-type plasminogen activator receptor (uPA-R) in papillary carcinoma of the thyroid.
Zanetti A; Stoppacciaro A; Marzullo A; Ciabatta M; Fazioli F; Prat M; Comoglio PM; Baroni CD; Ruco LP
J Pathol; 1998 Nov; 186(3):287-91. PubMed ID: 10211118
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications.
Chevillard S; Ugolin N; Vielh P; Ory K; Levalois C; Elliott D; Clayman GL; El-Naggar AK
Clin Cancer Res; 2004 Oct; 10(19):6586-97. PubMed ID: 15475448
[TBL] [Abstract][Full Text] [Related]
17. Galectin-3 expression in papillary thyroid carcinoma: relation to histomorphologic growth pattern, lymph node metastasis, extrathyroid invasion, and tumor size.
Cvejic DS; Savin SB; Petrovic IM; Paunovic IR; Tatic SB; Havelka MJ
Head Neck; 2005 Dec; 27(12):1049-55. PubMed ID: 16155918
[TBL] [Abstract][Full Text] [Related]
18. Met protein and hepatocyte growth factor (HGF) in papillary carcinoma of the thyroid: evidence for a pathogenetic role in tumourigenesis.
Ruco LP; Stoppacciaro A; Ballarini F; Prat M; Scarpino S
J Pathol; 2001 May; 194(1):4-8. PubMed ID: 11329134
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of expression of bcl-2 protein in papillary carcinomas and papillary microcarcinomas of the thyroid gland.
Mitselou A; Peschos D; Dallas P; Charalabopoulos K; Agnantis NJ; Vougiouklakis T
Exp Oncol; 2004 Dec; 26(4):282-6. PubMed ID: 15627060
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and prognostic significance of tall cell variant of papillary thyroid carcinoma.
Michels JJ; Jacques M; Henry-Amar M; Bardet S
Hum Pathol; 2007 Feb; 38(2):212-9. PubMed ID: 17097131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
